Company Details
- Employees
- 30
- Founded
- -
- Address
- 3600 Minnesota Dr,
- Industry
- Construction
- NAICS
-
Construction
- Website
- spectruminteriors.us.com
- HQ
- Edina, Minnesota
Please complete the CAPTCHA to continue
Related company profiles:
Consumer confidence dips as markets rally The Real Economy Blog
Comparative Accuracy of Colonoscopy, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI) for the Preoperative Localization of Colorectal Cancer: A Prospective Cohort Study Cureus
Daily Digest: Top news from October 28 Insurance Insider US
Chrysler Faces Class Action Lawsuit Over Key Programmer Theft Claims Motorious
EY US - Home | Building a better working world EY
Driving change: The new roadmap for automotive retail transformation RSM
Prolonged Attachment of Rhipicephalus microplus Tick Without Systemic Manifestations: A Case Report Cureus
California proposes regs requiring insurers to report climate, AI risk scenarios Insurance Insider US
Massive Nationwide Cancer Charity Fraud Scheme Serves as Warning Oncology News Central
Parry-Romberg Syndrome With Localized Scleroderma: A Report of Two Pediatric Cases From Oman Cureus
American Rheinmetall Munitions and Solugen to formalize partnership Rheinmetall
Holly Starks Acquires the Flumberico Brand, Expanding the Vision Behind flumberico.us.com Yahoo Finance
FM appoints Liberty Mutual’s Erbig as new CFO Insurance Insider US
AdvaMed Code of Ethics® AdvaMed® - Advanced Medical Technology Association®
FLUMIST® (Influenza, Vaccine Live, Intranasal), the nation’s only nasal spray flu vaccine, now available for home delivery AstraZeneca US
Market Minute: Falling bond yields and economic imbalances The Real Economy Blog
BofA Launches ‘Golf with Us’ to Bring Affordable Rounds to More Than 50,000 Youth Nationwide Bank of America
Computed Tomography Coronary Angiogram as a First-Line Diagnostic Tool in Pregnancy-Associated Spontaneous Coronary Artery Dissection: A Case Report of Left Main Stem and Left Anterior Descending Artery Dissection at 35 Weeks' Gestation Cureus
Hypoalbuminemia and Nutritional Status in Docetaxel-Induced Erythema Multiforme: A Case Report Cureus
The Association Between Cytomegalovirus Infection and Increased Leukemia Incidence: A Retrospective Matched Cohort Cureus
Car donation charity fined millions, accepts fundraising restrictions in Colorado and 18 other states CBS News
U.S.A. Home Hitachi Global
Empowering Action in Asthma Care This Season and Beyond AstraZeneca US
iPR Pharmaceuticals Earns its 1st EPA’s ENERGY STAR® Certification for Superior Energy Efficiency AstraZeneca US
AstraZeneca impact in the US AstraZeneca US
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer AstraZeneca US
Our impact, our people AstraZeneca US
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D AstraZeneca US
Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III trial AstraZeneca US
AIRSUPRA ® (albuterol/budesonide) US prescribing information updated to reflect the statistically significant severe exacerbation risk reduction in patients with mild asthma compared with albuterol AstraZeneca US
Delaware AG joins lawsuit against 'deceptive' breast cancer fundraising operation The News Journal
Nationwide Fake Cancer Charity Scam Busted, Kars-R-Us.com Inc. Accused Hoodline
Congress nullifies IRS crypto reporting regulations for DeFi platforms RSM
Statistically significant and clinically meaningful BATURA Phase III trial results provide new evidence for AIRSUPRA as standard of care for as-needed rescue treatment in asthma AstraZeneca US
Partnerships in Motion: How Cross-Sector Collaboration is Powering Broader Clinical Trial Representation AstraZeneca US
AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial AstraZeneca US
Eneboparatide met primary endpoint of normalizing serum calcium in adults with hypoparathyroidism at 24 weeks in CALYPSO Phase III trial AstraZeneca US
American Rheinmetall secures order for T-158 tracks Rheinmetall
Rheinmetall completes acquisition of Loc Performance in the USA Rheinmetall
Announcing the 2024-2025 US ACT on Health Equity Community Investments Recipients AstraZeneca US
Collective Action to Advance Health Equity AstraZeneca US
FASENRA approved in the US for eosinophilic granulomatosis with polyangiitis AstraZeneca US
Affordability AstraZeneca US
What science can do AstraZeneca US
AIRSUPRA (PT027) approved in the US for asthma AstraZeneca US
Announcing the 2023 Power of Us Award winners AstraZeneca US
Scot Anderson Womble Bond Dickinson
The Real Economy: October 2025 RSM
TAGRISSO® (osimertinib) granted Priority Review in the US for patients with unresectable, Stage III EGFR-mutated lung cancer AstraZeneca US
Tracy A. Bacigalupo Womble Bond Dickinson
Emergency Medicine: How Hospitals can Prepare for Life-threatening Bleeding AstraZeneca US
Investigator Sponsored Studies (ISS) Program Novo Nordisk U.S. Website
Rewards and benefits RSM
TEZSPIRE approved for self-administration in the US with a new pre-filled pen AstraZeneca US
Careers AstraZeneca US
Who We Are Otsuka US
AIRSUPRA® (albuterol/budesonide) demonstrated statistically significant and clinically meaningful reduction in the risk of severe exacerbations in patients with intermittent or mild persistent asthma in BATURA Phase III trial AstraZeneca US
FluMist approved for self-administration in the US AstraZeneca US
Contact Us AstraZeneca US
WAINUA (eplontersen) granted first-ever regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis AstraZeneca US
VOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH AstraZeneca US
Product patents Novo Nordisk U.S. Website
ispace - U.S. Announces new U.S. Headquarters, Unveils APEX 1.0 Lunar Lander, Provides Updates on Mission 3 ispace
TAGRISSO® (osimertinib) approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer AstraZeneca US
Alexander P. Wharton Womble Bond Dickinson
Athletes Team USA
Capivasertib in combination with FASLODEX® (fulvestrant) granted Priority Review in the US for patients with advanced HR-positive breast cancer AstraZeneca US
FARXIGA extended in the US to reduce risk of cardiovascular death and hospitalization for heart failure to a broader range of patients AstraZeneca US
Portraits of Lung Cancer AstraZeneca US
SAPHNELO (anifrolumab) approved in the US for moderate to severe systemic lupus erythematosus AstraZeneca US
Agreement to takeover US vehicle specialist Loc Performance Rheinmetall
BYDUREON BCise (exenatide extended-release) approved in the US for the treatment of type 2 diabetes in pediatric patients ages 10 years and older AstraZeneca US
Tezepelumab regulatory submission accepted and granted FDA Priority Review in the US for the treatment of patients with asthma AstraZeneca US
AstraZeneca’s Aradhana Sarin Named to CNBC’s 2024 Changemakers: Women Transforming Business List AstraZeneca US
Improving access and affordability Novo Nordisk U.S. Website
Personified: Bridget Therriault AstraZeneca US
LOKELMA® granted Fast Track Designation in the US to reduce cardiovascular outcomes in patients on chronic hemodialysis with hyperkalemia AstraZeneca US
AstraZeneca shares progress on LYNPARZA™ (olaparib) tablets in the US AstraZeneca US
Taking the Wheel in Diverse Clinical Trial Recruitment: Introducing AZ's AIRE Mobile Unit AstraZeneca US
US FDA approves new easy-to-use, once-weekly BYDUREON® BCise™ injectable medicine for patients with type-2 diabetes AstraZeneca US
AstraZeneca in the United States AstraZeneca US
ispace-U.S. to use Swedish Space Corporation’s Lunar Ground Station Network for its M3 Lunar Mission ispace
Product Disposal Novo Nordisk U.S. Website
CALQUENCE plus obinutuzumab demonstrated sustained survival benefit in 1st-line chronic lymphocytic leukemia with 90% of patients surviving five years in ELEVATE-TN trial AstraZeneca US
ENHERTU® (fam-trastuzumab deruxtecan-nxki) significantly improved both progression-free and overall survival in DESTINY-Breast04 trial in patients with HER2-low metastatic breast cancer AstraZeneca US
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know AstraZeneca US
Unaccompanied Child Migrants in U.S. Communities, Immigration Court, and Schools migrationpolicy.org
Diabetes Pen Needles Novo Nordisk U.S. Website
Bart LaCount Appointed Chief Marketing Officer and Matt Rubin Appointed Chief Digital Officer of Popeyes® U.S. & Canada Popeyes Newsroom
FASLODEX® (fulvestrant) receives US FDA approval for the treatment of advanced breast cancer in combination with abemaciclib AstraZeneca US
AstraZeneca US and Health Equity: Today & Tomorrow AstraZeneca US
AstraZeneca purchases US manufacturing facility to support biologics manufacturing capabilities AstraZeneca US
ULTOMIRIS® (ravulizumab-cwvz) approved in the US for adults with generalized myasthenia gravis AstraZeneca US
Meet our 2022 Power of Us Award Winners AstraZeneca US
The truth behind the ‘He Gets Us’ ads for Jesus airing during the Super Bowl CNN
Jonathan Reid Reich Womble Bond Dickinson
Grants & corporate giving Novo Nordisk U.S. Website
Employees Making an Impact in Their Communities AstraZeneca US
National High Potassium Awareness Day: Spreading the Word About High Potassium AstraZeneca US
US FDA approves SYMBICORT for the treatment of asthma in pediatric patients AstraZeneca US
Find emails, phones & company data instantly
Your AI prospecting assistant
0 records × $0.02 per record
Secure checkout
Total price
$0.50
Enter your payment details below to complete the download. We'll email you the CSV as soon as it's ready.
Processing your payment...
Please wait while we complete your transaction
Sign in required
Create a free account or sign in to continue downloading the full results.
Sign up for a free account. No credit card required. Up to 10 free credits.
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.